Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents Hofit CohenClaudia Stefanuttiand The Mighty Medic Satellite Research Group for Pediatric Dyslipidemia Statin Drugs (R. Ceska, Section Editor) Open access 08 May 2021 Article: 30
Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia Joan Carles Escolà-GilNoemí RotllanFrancisco Blanco-Vaca Vascular Biology (H. Pownall, Section Editor) 29 April 2021 Article: 29
How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management? Trevor D. HadleyAli M. AghaChristie M. Ballantyne Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 01 April 2021 Article: 28
Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment Fabien PicardPhilippe Gabriel Steg Cardiometabolic Disease and Treatment (E. Brinton, Section Editor) 31 March 2021 Article: 27
Metabolomic Biomarkers of Healthy Dietary Patterns and Cardiovascular Outcomes Hyunju KimCasey M. Rebholz Nutrition (K. Petersen, Section Editor) 30 March 2021 Article: 26
Understanding Immigration as a Social Determinant of Health: Cardiovascular Disease in Hispanics/Latinos and South Asians in the United States Jenny S. GuadamuzKaran KapoorUsama Bilal Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 27 March 2021 Article: 25
Food Insecurity and Cardiovascular Disease Risk Yibin LiuHeather A. Eicher-Miller Nutrition (K. Petersen, Section Editor) 27 March 2021 Article: 24
The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes W. Sean DavidsonAllison L. CookeAmy S. Shah Vascular Biology (H. Pownall, Section Editor) 27 March 2021 Article: 23
